Search

Kanaka Raju Koduri

from San Diego, CA
Age ~73
Get Report
Also known as:
Kanaka R Koduri, Kanaka Te Koduri, Raju K Koduri, Aruna Te Koduri, Kanakaraju Raju Koduri, Raj Koduri, Kanaka Kodori, U Koduri, Raju Kodura
Phone and address:
11893 Caminito Ryone, San Diego, CA 92128
Related to:
Megha KaduriAruna Koduri, 66
Connected to:
Anuradha Koduri, 74Jhansi L Koduri, 52Subash C Koduri, 41Chaitanya Koduru, 72Kiran R Koduru, 37Lavanya Koduru, 48Ram Koduru, 90Alphonsamma Koduvathra, 61Amritham N Koduvayur, 52Michael K Kodweis, 42

Kanaka Koduri Phones & Addresses

  • 11893 Caminito Ryone, San Diego, CA 92128
  • 4960 Clairemont Mesa Blvd, San Diego, CA 92117 (858) 874-0693
  • Fayetteville, NY
  • Union City, CA
  • 10262 Rancho Pl, Cupertino, CA 95014
  • White Plains, NY
  • Fremont, CA
  • Alameda, CA
  • 34767 Williams Way, Union City, CA 94587 (510) 928-8346

Work

Position: Machine Operators, Assemblers, and Inspectors Occupations

Education

Degree: Associate degree or higher

Publications

Us Patents

Expression Vectors Containing Hot Spot For Increased Recombinant Protein Expression In Transfected Cells

View page
US Patent:
6800457, Oct 5, 2004
Filed:
Dec 16, 2002
Appl. No.:
10/320176
Inventors:
Kanaka Raju Koduri - White Plains NY
John T. Miller - Syracuse NY
Pallaiah Thammana - Manlius NY
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
C12P 2102
US Classification:
435 691, 435 696, 435358, 4353201
Abstract:
A specific locus (hot spot) for recombinant gene expression has been identified in the genome of Chinese hamster ovary cells. A DNA vector containing the hot spot causes high levels of recombinant gene expression following transfection and stable integration. The selection and cloning of the specific locus and the expression of recombinant genes is disclosed, as are the DNA vectors and the host cells.

Compositions Of And Methods Of Using Stabilized Psma Dimers

View page
US Patent:
20090311225, Dec 17, 2009
Filed:
Nov 14, 2006
Appl. No.:
12/085040
Inventors:
Kanaka Raju Koduri - White Plains NY, US
Assignee:
PSMA Development Company, LLC - Tarrytown NY
International Classification:
A61K 38/17
C07K 14/47
C12N 15/12
C12N 15/85
C12N 5/10
A61K 31/7088
A61K 35/12
A61K 48/00
C12P 21/00
A61P 35/00
C12P 21/02
US Classification:
424 9321, 530350, 514 12, 536 235, 4353201, 435325, 514 44 R, 424 932, 435 696, 435 691
Abstract:
The invention includes cysteine-modified PSMA polypeptides and disulfide-bond-stabilized dimers thereof, compositions and kits containing the cysteine-modified PSMA polypeptides, including dimers thereof, as well as methods of producing and using these compositions. Such methods include methods for eliciting or enhancing an immune response to cells expressing PSMA, methods of producing antibodies to PSMA, including dimeric PSMA, as well as methods of treating cancer, such as prostate cancer.

Nonnatural Apolipoprotein B-100 Peptides And Apolipoprotein B-100-Apolipoprotein A-I Fusion Peptides

View page
US Patent:
54080380, Apr 18, 1995
Filed:
Oct 8, 1992
Appl. No.:
7/959946
Inventors:
Richard S. Smith - Del Mar CA
Linda K. Curtiss - San Diego CA
Kanaka R. Koduri - San Diego CA
Joseph L. Witztum - San Diego CA
Stephen G. Young - Hillsborough CA
Assignee:
The Scripps Research Institute - La Jolla CA
International Classification:
C07K 1516
C07H 2104
G01N 3353
US Classification:
530359
Abstract:
Methods and compositions are described for determining the level of low density lipoproteins (LDL) in plasma. Native apoprotein B-100 (apo B-100) present in LDL particles is immunologically mimicked by a polypeptide of the invention. A polypeptide includes an amino acid residue sequence corresponding to a pan epitope region of the target apoprotein. A preferred polypeptide is a fusion protein that simultaneously mimics native apo B-100 and native apo A-I. Improved assay systems and methods for determining HDL and LDL levels in a body fluid sample are also described.

Dna Encoding Recombinant Lipoprotein Antigens

View page
US Patent:
57862060, Jul 28, 1998
Filed:
Oct 31, 1994
Appl. No.:
8/333577
Inventors:
Richard S. Smith - Del Mar CA
Linda K. Curtiss - San Diego CA
Kanaka Raju Koduri - San Diego CA
Joseph L. Witztum - San Diego CA
Stephen G. Young - Hillsborough CA
Assignee:
The Scripps Research Institute - LaJolla CA
International Classification:
C12N 121
C12N 1563
C07H 2104
C07K 14775
US Classification:
43525233
Abstract:
Methods and compositions are described for determining the level of low density lipoproteins (LDL) in plasma. Native apoprotein B-100 (apo B-100) present in LDL particles is immunologically mimicked by a polypeptide of the invention. A polypeptide includes an amino acid residue sequence corresponding to a pan epitope region of the target apoprotein. A preferred polypeptide is a fusion protein that simultaneously mimics native apo B-100 and native apo A-I. Improved assay systems and methods for determining HDL and LDL levels in a body fluid sample are also described.
Control profile
Kanaka Raju Koduri from San Diego, CA, age ~73 Get Report